Our observations that p38 MAPK and JNK phosphorylation were downregulated after fasting in the liver support the notion that more research/clinical studies are required to explore the benefits of fasting in improving the potency of tyrosine kinase inhibitors in cancer treatment. Here, MAPK8 is linked to cancer.